Glycosylphosphatidylinositol
Glycosylphosphatidylinositol (GPI) is a glycolipid that can be attached to the C-terminus of a protein during posttranslational modification. It is composed of a phosphatidylinositol group linked through a carbohydrate-containing linker (glucosamine and mannose glycosidically bound to inositol) to the C-terminal amino acid of a mature protein.
Structure[edit]
The GPI anchor is a complex glycolipid that links proteins to the cell surface. The core structure of the GPI anchor is conserved across all eukaryotes, and consists of ethanolamine phosphate, three mannose residues, a non-N-acetylated glucosamine, and a molecule of phosphatidylinositol. The phosphatidylinositol can be acylated at the inositol ring by a fatty acid chain.
Function[edit]
GPI-anchored proteins (GPI-APs) have various functions including enzyme activities, receptor activities, adhesion, and antigenicity. They are found on the surface of various types of cells, including erythrocytes, lymphocytes, and macrophages. GPI-APs are also involved in several diseases, such as paroxysmal nocturnal hemoglobinuria (PNH) and African sleeping sickness.
Biosynthesis[edit]
The biosynthesis of GPI is a complex process that occurs in the endoplasmic reticulum (ER). It involves the sequential addition of sugars and other components to phosphatidylinositol. The process is initiated by the transfer of N-acetylglucosamine from UDP-N-acetylglucosamine to phosphatidylinositol.
Clinical significance[edit]
Defects in GPI biosynthesis are associated with several diseases, including PNH and inherited GPI deficiency. In PNH, the most common clinical manifestation is hemolytic anemia due to the increased sensitivity of erythrocytes to complement-mediated lysis.
Sponsored Health Resource

W8MD Weight Loss, Sleep & MedSpa
Looking for physician-supervised weight loss, semaglutide, tirzepatide, or GLP-1 receptor agonist options? W8MD helps eligible patients in New York City, Brooklyn, New Jersey, Connecticut, Pennsylvania, Delaware, and greater Philadelphia with medical weight loss, sleep medicine, and long-term maintenance support.
GLP-1 specials: Affordable GLP-1 injections NYC and Philadelphia starting from $29.99/week and up for semaglutide with insurance accepted for qualifying visits, and $45/week and up for tirzepatide with insurance accepted for qualifying visits. Self-pay options start from $59.99/week and up for semaglutide and $69.99/week and up for tirzepatide.
- Medical weight loss NYC
- Affordable GLP-1 injections NYC
- Budget GLP-1 weight loss shots Philadelphia
- New Jersey medical weight loss
- NYC medical weight loss blog
- Philadelphia weight loss blog
- Sleep medicine and sleep apnea services
- W8MD MedSpa and wellness
Book a W8MD appointment · View GLP-1 specials
Paid promotional message. Eligibility, pricing, insurance coverage, medication availability, and results vary. Medical evaluation required.
Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Translate page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian